Estrogen receptor beta decreases survival of p53-defective cancer cells after DNA damage by impairing G₂/M checkpoint signaling (Q34125558)

31 July 2017

Estrogen receptor beta decreases survival of p53-defective cancer cells after DNA damage by impairing G₂/M checkpoint signaling (English)

1 reference

31 July 2017

0 references

1 reference

Christoforos G Thomas

1

1 reference

31 July 2017

Anders Strom

2

1 reference

31 July 2017

Karolina Lindberg

3

1 reference

31 July 2017

Jan-Ake Gustafsson

4

1 reference

31 July 2017

language of work or name

English

0 references

publication date

10 July 2010

1 reference

Breast Cancer Research and Treatment

31 July 2017

1 reference

31 July 2017

127

1 reference

31 July 2017

2

1 reference

31 July 2017

417-427

1 reference

https://scigraph.springernature.com/pub.10.1007/s10549-010-1011-z

31 July 2017

0 references

cites work

Checkpoints: controls that ensure the order of cell cycle events

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1011-Z

Live or let die: the cell's response to p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1011-Z

21 January 2018

Surfing the p53 network

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1011-Z

Therapeutic exploitation of checkpoint defects in cancer cells lacking p53 function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1011-Z

Association of BRCA1 with Rad51 in mitotic and meiotic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1011-Z

BRCA1 activates a G2-M cell cycle checkpoint following 6-thioguanine-induced DNA mismatch damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1011-Z

Brca1 controls homology-directed DNA repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1011-Z

Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1011-Z

A targeted disruption of the murine Brca1 gene causes gamma-irradiation hypersensitivity and genetic instability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1011-Z

Loss of BRCA1 function increases the antitumor activity of cisplatin against human breast cancer xenografts in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1011-Z

The role of BRCA1 in the cellular response to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1011-Z

Therapeutic exploitation of tumor cell defects in homologous recombination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1011-Z

p53 mediates repression of the BRCA2 promoter and down-regulation of BRCA2 mRNA and protein levels in response to DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1011-Z

Tumor suppressor p53 is required to modulate BRCA1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1011-Z

Cloning of a novel receptor expressed in rat prostate and ovary

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1011-Z

Estrogen receptor beta--a new dimension in estrogen mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1011-Z

ER beta inhibits proliferation and invasion of breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1011-Z

Estrogen receptor beta inhibits 17beta-estradiol-stimulated proliferation of the breast cancer cell line T47D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1011-Z

Estrogen receptor beta inhibits angiogenesis and growth of T47D breast cancer xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1011-Z

Estrogen receptor beta inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1011-Z

Estrogen receptor (ER) beta or p53 attenuates ERalpha-mediated transcriptional activation on the BRCA2 promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1011-Z

Small-molecule RETRA suppresses mutant p53-bearing cancer cells through a p73-dependent salvage pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1011-Z

Chk1 and Chk2 kinases in checkpoint control and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1011-Z

Cell death by mitotic catastrophe: a molecular definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1011-Z

The cell cycle checkpoint kinase Chk2 is a negative regulator of mitotic catastrophe

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1011-Z

Caspase-2 function in response to DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1011-Z

Chk1 suppresses a caspase-2 apoptotic response to DNA damage that bypasses p53, Bcl-2, and caspase-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1011-Z

Estrogen receptor acting in cis enhances WT and mutant p53 transactivation at canonical and noncanonical p53 target sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1011-Z

Recent advances in cancer therapy targeting proteins involved in DNA double-strand break repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1011-Z

The cdc25 protein contains an intrinsic phosphatase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1011-Z

Human cyclins A and B1 are differentially located in the cell and undergo cell cycle-dependent nuclear transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1011-Z

Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1011-Z

Purification and molecular cloning of Plx1, a Cdc25-regulatory kinase from Xenopus egg extracts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1011-Z

Positive feedback activation of estrogen receptors by the CXCL12-CXCR4 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1011-Z

Evaluation of biological pathways involved in chemotherapy response in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1011-Z

Differential regulation of estrogen receptor alpha turnover and transactivation by Mdm2 and stress-inducing agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1011-Z

A single-nucleotide polymorphism in a half-binding site creates p53 and estrogen receptor control of vascular endothelial growth factor receptor 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1011-Z

p53-deficient cells rely on ATM- and ATR-mediated checkpoint signaling through the p38MAPK/MK2 pathway for survival after DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1011-Z

10.1007/S10549-010-1011-Z

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

31 July 2017

0 references

1 reference